Tianjin Ringpu Bio Tech - Asset Resilience Ratio

Latest as of March 2026: 14.27%

Tianjin Ringpu Bio Tech (300119) has an Asset Resilience Ratio of 14.27% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.11 Billion
≈ $162.89 Million USD Cash + Short-term Investments

Total Assets

CN¥7.80 Billion
≈ $1.14 Billion USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Tianjin Ringpu Bio Tech's Asset Resilience Ratio has changed over time. Check Tianjin Ringpu Bio Tech strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Tianjin Ringpu Bio Tech's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300119 market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.11 Billion 14.27%
Total Liquid Assets CN¥1.11 Billion 14.27%

Asset Resilience Insights

  • Moderate Liquidity: Tianjin Ringpu Bio Tech has 14.27% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Tianjin Ringpu Bio Tech Industry Peers by Asset Resilience Ratio

Compare Tianjin Ringpu Bio Tech's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
Drug Manufacturers - Specialty & Generic 2.04%
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
Drug Manufacturers - Specialty & Generic 0.01%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%
Jw Pharmac
KO:001060
Drug Manufacturers - Specialty & Generic 3.65%
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Samjin Pharm
KO:005500
Drug Manufacturers - Specialty & Generic 0.25%

Annual Asset Resilience Ratio for Tianjin Ringpu Bio Tech (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Tianjin Ringpu Bio Tech.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 13.62% CN¥1.04 Billion
≈ $152.58 Million
CN¥7.66 Billion
≈ $1.12 Billion
-4.60pp
2024-12-31 18.22% CN¥1.45 Billion
≈ $212.36 Million
CN¥7.97 Billion
≈ $1.17 Billion
-1.24pp
2023-12-31 19.46% CN¥1.28 Billion
≈ $187.80 Million
CN¥6.60 Billion
≈ $965.19 Million
-5.12pp
2022-12-31 24.58% CN¥1.50 Billion
≈ $219.62 Million
CN¥6.11 Billion
≈ $893.54 Million
+14.42pp
2021-12-31 10.15% CN¥577.88 Million
≈ $84.56 Million
CN¥5.69 Billion
≈ $832.74 Million
-0.10pp
2020-12-31 10.25% CN¥399.83 Million
≈ $58.51 Million
CN¥3.90 Billion
≈ $570.58 Million
-0.56pp
2019-12-31 10.81% CN¥385.29 Million
≈ $56.38 Million
CN¥3.56 Billion
≈ $521.42 Million
+1.57pp
2018-12-31 9.25% CN¥277.21 Million
≈ $40.56 Million
CN¥3.00 Billion
≈ $438.77 Million
+2.14pp
2017-12-31 7.11% CN¥207.80 Million
≈ $30.41 Million
CN¥2.92 Billion
≈ $427.90 Million
-2.54pp
2016-12-31 9.64% CN¥263.60 Million
≈ $38.57 Million
CN¥2.73 Billion
≈ $399.95 Million
+6.69pp
2015-12-31 2.95% CN¥69.30 Million
≈ $10.14 Million
CN¥2.35 Billion
≈ $343.67 Million
--
pp = percentage points

About Tianjin Ringpu Bio Tech

SHE:300119 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.17 Billion
CN¥8.00 Billion CNY
Market Cap Rank
#8135 Global
#1842 in China
Share Price
CN¥17.22
Change (1 day)
+1.18%
52-Week Range
CN¥14.38 - CN¥23.48
All Time High
CN¥39.94
About

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and p… Read more